Forum
![](/images/Oa.jpg)
Drug Alert: Eprex (recombinant human erythropoeitin alfa) and pure red cell aplasia - recommendations for administration to patients with CRF
Author's affiliations
National Adverse Drug Monitoring Centre, Medicines Control Council, HMPG
Full Text
![](/images/icons/PDF.png)
Cite this article
Article History
Date published: 2008-07-30
Article Views
Full text views: 1322
Comments on this article
*Read our policy for posting comments here